Topics

Articles

When entering the specialty pharmaceuticals arena, manufacturers need to evaluate the capabilities of their channel partners carefully

What manufacturers should anticipate when working with specialty pharmacies

HDMA's fourth edition polling its members and manufacturers, on trends in specialty distribution

Specialty Pharmaceuticals: Facts and Figures

Improving efficiency, effectiveness of drug recalls

Serialization systems are going into operation around the world, but cross-industry collaboration awaits new legislation

2012 Product Security Report

With partial support from manufacturers themselves, home health services are emerging as a critical channel for specialties

Home infusion enhances specialty pharmaceutical distribution

Oncology combines some of the most life-changing therapeutic events with the most complex commercialization pathways. Rising costs of treatments simply add to the tension

Navigating the tense, complex oncology market

As FDA makes progress on an active surveillance system, drug manufacturers and third-party drug safety vendors navigate their own set of challenges

Adding rigor to the adverse event reporting process

But the global picture is sunny as most of the global market growth benefits the generic makers

Generics Manufacturers Grapple With Tight Economics

Even as diagnosed (and “prediabetes”) cases rise worldwide, healthcare providers struggle with patients to control the course of the disease. New therapies—and new health services—are aiding in the battle

Brand & Product Security